Novo Nordisk to pay $2 billion for new weight loss drug
Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity ...
MM&M19d
Novo Nordisk welcomes patients to the Ozempic Era
The Ozempic shortage is over and the Ozempic era is here. Novo Nordisk launched its latest campaign – My Ozempic Era – just a few weeks after the Food and Drug Administration took semaglutide, the ...
Becker's Hospital Review1d
Will FDA deadlines reduce compounded versions of Ozempic?
With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic ...
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
Novo Nordisk Stock Rises Ahead of Data on Ozempic Ingredient's Ability to Lower Heart Risk
Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ...
Yahoo Finance15d
Novo Nordisk's Ozempic successor disappointed Wall Street again
Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time. The pharmaceutical giant, known for its blockbuster ...
NBC Los Angeles2d
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Eli Lilly's pill works in a similar way to Wegovy, Ozempic, and Novo Nordisk's diabetes pill ... could benefit from treatment but are afraid of needles. Th pill could also tap into new markets ...